31.03.2024, 1226 Zeichen

S Immo: Total revenues of real estate company S Immo increased from EUR 260.5m in the previous year to EUR 336.5m. This is due, among other things, to successful acquisitions in Austria and the Czech Republic. The result from property valuation was negative at EUR -109.3m (2022: EUR -78.4m), which is mainly due to the current difficult economic conditions. Gross profit increased significantly to EUR 179.3m. BITDA reached EUR 142.6m, the highest figure in the company's history. "In the third quarter of 2023, we established the Czech Republic as another core market for S IMMO and have already acquired a large, profitable portfolio in this context. We are also working intensively on the acquisition of a further portfolio of office and retail properties with a total leasable area of around 134,600 m², a total asset value of EUR 494.5m and annual rental income of around EUR 28m and have already signed a non-binding letter of intent" says Tomáš Salajka, member of the Management Board. "All of these acquisitions will help us to further improve and increase the strong operating result of 2023."
S Immo: weekly performance: 6.79%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (25/03/2024)

Christian Drastil: Wiener Börse Plausch

BörseGeschichte Podcast: Gerald Grohmann vor 10 Jahren zum ATX-25er

Bildnachweis

Aktien auf dem Radar:Polytec Group, Addiko Bank, UBM, RHI Magnesita, Zumtobel, Agrana, Rosgix, CA Immo, DO&CO, SBO, Gurktaler AG Stamm, Heid AG, OMV, Wolford, Palfinger, Rosenbauer, Oberbank AG Stamm, BTV AG, Flughafen Wien, BKS Bank Stamm, Josef Manner & Comp. AG, Mayr-Melnhof, Athos Immobilien, Marinomed Biotech, Amag, Österreichische Post, Verbund, Wienerberger, Merck KGaA, Continental, Fresenius Medical Care.

---